SEC Form 4 Summary HALO

Halozyme CEO Helen Torley sells 60,000 shares

Halozyme Therapeutics CEO Helen Torley sold 60,000 HALO shares for $6,000,685.54 across 10 transactions.

Transaction Value:
$6,000,685.54
Shares transacted:
60,000
Average price:
$100.01
Insider:

The Form 4 filing, an SEC report of an insider's stock trades, was filed on November 16, 2026. The reported sales span November 12 through November 16. Helen Torley serves as president and CEO of Halozyme Therapeutics (HALO).

Transaction details

Transaction
Date of Earliest Transaction2026-11-12
Date of Latest Transaction2026-11-16
Buy/Sellsell
Transaction Count10
Shares Transacted60,000
Price$100.01
Total Transaction Value$6,000,685.54
Insider
Ticker SymbolHALO
CompanyHALOZYME THERAPEUTICS, INC.
Insider NameTorley Helen
Insider TitlePRESIDENT AND CEO
Sector - IndustryHealthcare - Biotechnology
Holdings
Total Shares Owned After Transaction767,780
Position Size Change7.25%
Filing
Filing Date2026-11-16
SEC LinkView filing

FAQ

What type of transaction is this?

These were share sales reported under SEC transaction code S. They involved 60,000 shares across 10 transactions in a single filing.

What was the average price of the transaction?

The average sale price was $100.01 per share across the 10 transactions. The available details do not give a separate price for each sale.

How did this transaction affect the insider's holdings?

She sold 60,000 shares and reported 767,780 shares owned afterward. The sales represented 7.25% of the shares she owned before the sales.

What's the total transaction value?

The 10 transactions had a total value of $6,000,685.54, rounded to cents from $6,000,685.537.

Are there any special circumstances around this transaction?

Yes. The available details include a Rule 10b5-1 trading-plan reference. These plans set trading instructions in advance. Footnote text and plan terms were not provided, so it is unclear which of the 10 sales the reference covers. The plan's adoption date and trading schedule are also unknown. The reference alone does not confirm that the sales met all of the rule's conditions.

For research purposes only; not investment advice.

Follow the Newswire
Feedly RSS feed
About RSS

Get new articles in your feed reader as they are published. Add our RSS feed to Feedly or another RSS reader.

Instant SEC Form 4 alerts

Get the next insider trade alert in real time.

Follow the filings behind the headlines. Get matching insider trade alerts sent straight to your email or Telegram, with links to the original SEC filings. Choose Premium for instant alert delivery and ticker-level filters.

Try instant alerts free 10 trading days · No credit card required

Pricing

Free Trial

10 trading days
$0

Explore every Premium feature before you pay.

  • Full platform access
  • 10 trading days
  • No credit card required
  • 20 years of alert history
  • Live alert directory updates
Start your free trial

Standard Monthly

Scheduled
$19.99 / month

Scheduled alerts with complete trade context.

  • Email and Telegram delivery
  • Alert intervals from every sixty minutes to once daily
  • Filter by insider title, buy/sell, transaction value, DRIP, ESPP, 10b5-1, and tax liability coverage transfers
  • Highlighted cluster transactions and SEC filing links
  • Access to the alert directory hourly refreshes
Choose Standard Monthly

Premium Monthly

Recommended
$29.99 / month

Fastest alerts with ticker-level control.

Choose Premium Monthly
Student discount: Customers who sign up with a verified .edu email address receive 50% off for the first four years. On monthly plans, the first month is the full 75% off.
Alerts are based on public SEC filings and are provided for informational purposes only; they do not constitute financial advice.